[1]CurrentPatentAssignee:XENONPHARMACEUTICALSINC-US2018/162868,2018,A1Locationinpatent:Paragraph1066-1067
100155-73-5
1015846-40-8
1256633-17-6
1215107-39-3
138175-25-4
27854-90-6
1269394-29-7 | {[1-(2-methylphenyl)-3-pyrrolidinyl]methyl}amine hydrochloride | AA00J1OQ | MFCD18483430
1158376-51-2 | N-isopropyl-N-methyl-beta-alanine hydrochloride | AA00J1S7 | MFCD09864591
1269376-61-5 | 1-(3-fluorobenzyl)-1H-pyrazol-4-amine dihydrochloride | AA00J1V0 | MFCD18205900
1269105-90-9 | 2-[(3-aminobenzyl)(methyl)amino]ethanol dihydrochloride | AA00J1XJ | MFCD18483482
13022-87-2 | (3-aminobutyl)dimethylamine | AA00J20Z | MFCD09742179
957312-71-9 | 5-(1,5-Dimethyl-1H-pyrazol-4-yl)isoxazole-3-carboxylic acid | AA00J23Q | MFCD04969981
73611-42-4 | rac-(1R,2R,6S,7S)-10-oxa-4-azatricyclo[5.2.1.0~2,6~]decane | AA00J276 | MFCD18917046
1609401-01-5 | 3-Propyl-1h-1,2,4-triazole hydrochloride | AA00J2A7 | MFCD26959460
2154-81-6 | 4-(3,5-Dimethylisoxazol-4-yl)benzene-1-sulfonyl chloride | AA00J2DT | MFCD16340726
1332529-43-7 | 1-(2-pyrazinyl)-3-piperidinamine dihydrochloride | AA00J2GH | MFCD19103266